Free Access
| Issue |
J Extra Corpor Technol
Volume 43, Number 1, March 2011
|
|
|---|---|---|
| Page(s) | 30 - 33 | |
| DOI | https://doi.org/10.1051/ject/201143030 | |
| Published online | 15 March 2011 | |
- Ravikumar TS, Pizzorno G, Bodden W, et al. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. J Clin Oncol. 1994;12:2723–36. [CrossRef] [PubMed] [Google Scholar]
- Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5–26. [CrossRef] [PubMed] [Google Scholar]
- Rothenberg MC, Oza AM, Bigelow RH, et al. Superiority of oxaliplatin and fluorouracil leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin interim results of a phase III trial. J Clin Oncol. 2003;21:2059–69. [CrossRef] [PubMed] [Google Scholar]
- Kemeny N, Gonen M, Sullivan D, et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol. 2001;19:2687–95. [CrossRef] [PubMed] [Google Scholar]
- Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32:239–51. [CrossRef] [Google Scholar]
- Farma JM, Pingpank JF, Libutti SK, et al. Percutaneous hepatic perfusion (PHP) with melphalan for patients with metastatic melanoma (MM) to the liver. Abstract 10068. Surgery Branch, National Cancer Institute. [Google Scholar]
- Alexander HR, Bartlett DL, Libutti SK. Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver. Oncologist. 2000;5:416–24. [CrossRef] [PubMed] [Google Scholar]
- Pingpank JF, Libutti SK, Chang R, et al. Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol. 2005;23:3465–74. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.